BDO Says That Biotech Has Seen a Significant Increase in Compensation
As a sponsor for the third annual OneMedForum New York to be held July 11-12, BDO Life Sciences will host a special workshop to discuss compensation practices at life sciences companies.
Read more »A Decade of War Pushes PTSD To the Forefront in Healthcare Concerns
As the US begins to see more and more soldiers return home from combat after the last decade of wars, finding a viable treatment for PTSD should and will be a more prominent concern in the minds of many.
Read more »Agilent Technologies Acquires Cancer Diagnostics Company, Dako In Largest Acquisition To Date
OneMedForum New York 2012 will offer a diagnostics panel session on the afternoon of July 12th to discuss the rapid technological advances in diagnostics and personalized medicine.
Read more »InVivo Therapeutics Protects And Regenerates The Spinal Cord Resulting in Functional Improvement Below the Injury
Frank Reynolds, of InVivo Therapeutics (NVIV), says the company is on the verge of unprecedented technology for the treatment of the spinal cord.
Read more »June 2012
In our June Research Report, OneMedResearch explores the potential impact of the JOBS Act on the life sciences sector. This […]
Read more »June 21, 2012 Healthcare Transformation & Innovation
Hosted by the Executive Council June 21, 2012 Hearst Tower New York With Supreme Court hearings on President Obama’s healthcare law imminent, […]
Read more »Zymeworks Invited to Present AntiBody Technology at OneMedForum NY 2012
Zymeworks Inc. is a privately held biotechnology company committed to developing best-in-class protein therapeutics for the treatment of cancer.
Read more »The Greater Zurich Area AG To Sponsor Swiss Themed Reception at OneMedForum New York 2012
The Greater Zurich Area AG is responsible for promoting and marketing one of the world’s leading Life Sciences and MedTech hubs.
Read more »Advaxis ADXS-PSA Construct Causes Significant Tumor Regression in Preclinical Prostate Cancer Study
According to the American Cancer Society, prostate cancer is the most common type of cancer found in American men, other than skin cancer.
Read more »OncoSec to Present at Upcoming Investor and Scientific Conferences
OncoSec Medical is a biopharmaceutical company developing advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers and metastatic disease.
Read more »